Advertisement

Search Results

Advertisement



Article Topics

Your search for Julie M. Vose, MD, MBA, FASCO matches 1 pages

Showing 1 - 1


multiple myeloma

ASCO 2016: Autologous Stem Cell Transplant Remains Relevant in Multiple Myeloma, Even in Era of Novel Agents

Early findings from a phase III clinical trial (EMN02/HO95 MM) showed that patients with multiple myeloma who received an autologous stem cell transplant survived longer without disease progression than those who received only chemotherapy using novel agents. This is the largest study reported to...

Advertisement

Advertisement



Advertisement